Supplementary References (Cited in Supplementary Table 6)

Supplementary References (cited in Supplementary Table 6)

[1] Baumgartner MR, Hörster F, Dionisi-Vinci C et al (2014) Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia.Orphanet J Rare Dis 9:130. doi: 10.1186/s13023-014-0130-8.

[2] Hörster F, Garbade SF, Zwickler T et al (2009) Prediction of outcome in isolated methylmalonic acidurias: combined use of clinical and biochemical parameters. J Inherit Metab Dis 32: 630-9.

[3] Nicolaides P, Leonard J, Surtees R (1998) Neurological outcome ofmethylmalonicacidaemia. Arch Dis Child 78: 508-12.

[4]Heidenreich R, Natowicz M, Hainline BE et al (1988) Acute extrapyramidal syndrome in methylmalonicacidemia: “metabolic stroke” involving the globuspallidus. J Pediatr 113: 1022-7.

[5]Imen M, Hanene B, Ichraf K et al (2012) Methylmalonicacidemia and hyperglycemia: an unusual association. Brain Dev 34: 113-4.

[6] Prada CE, Al Jasmi F, Kirk EP et al (2011) Cardiac disease in methylmalonicacidemia. J Pediatr 159: 862-4.

[7] Tabanlioğlu D, Ersoy-Evans S, Karaduman A (2009). Acrodermatitisenteropathica-like eruption in metabolic disorders: acrodermatitisdysmetabolica is proposed as a better term. PediatrDermatol 26: 150-4.

[8]Haberlandt E, Canestrini C, Brunner-Krainz M et al (2009). Epilepsy in patients with propionic acidemia.Neuropediatrics 40: 120-5.

[9] Scholl-Bürgi S, Haberlandt E, Gotwald T et al (2009). Stroke-like episodes in propionic acidemia caused by central focal metabolic decompensation.Neuropediatrics40: 76-81.

[10] Grünert SC, Müllerleile S, De Silva L et al (2013) Propionic acidemia: clinical course and outcome in 55 pediatric and adolescent patients. Orphanet J Rare Dis 8:6.doi: 10.1186/1750-1172-8-6.

[11] Romano S, Valayannopoulos V, Touati G et al (2010) Cardiomyopathies in propionic aciduria are reversible after liver transplantation. J Pediatr 156: 128-34.

[12] Massoud AF, Leonard JV (1993) Cardiomyopathy in propionic acidaemia. Eur J Pediatr 152: 441-5.

[13]Bhan AK, Brody C (2001) Propionic acidemia: a rare cause of cardiomyopathy. Congest Heart Fail 7: 218-219.

[14] Lam C, Desviat LR, Perez-Cerdá C et al (2011) 45-Year-old female with propionic acidemia, renal failure, and premature ovarian failure; late complications of propionic acidemia? Mol Genet Metab 103: 338-40.

[15]Dweikat IM, Naser EN, Abu Libdeh Al et al (2011) Propionic acidemia mimicking diabetic ketoacidosis. Brain Dev 33: 428-31.

[16] Grünert SC, Wendel U, Lindner M et al (2012) Clinical and neurocognitive outcome in symptomatic isovalericacidemia. Orphanet J Rare Dis 7:9. doi: 10.1186/1750-1172-7-9.

[17]Qadi AM, Hamadah HK, Jijeh AM et al (2014) Ebstein cardiac anomaly, functional pulmonary atresia and isolvaericacidemia: A case report. J Saudi Heard Assoc 26: 170-3.

[18]Kölker S, Garbade SF, Greenberg CR et al (2006) Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 59: 840-7.

[19] Heringer J, Boy SP, Ensenauer R et al (2010) Use of guidelines improves the neurological outcome in glutaric aciduria type I. Ann Neurol 68: 743-52.

[20] Burlina AP, Zara G, Hoffmann GF, Zschocke J, Burlina AB (2004) Management of movement disorders in glutaryl-CoA dehydrogenase deficiency: anticholinergic drugs and botulinum toxin as additional therapeutic options. J Inherit Metab Dis 27: 911-5.

[21] Harting I, Neumaier-Probst E, Seitz A et al (2009) Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I. Brain 132: 1764-82.

[22] Beauchamp MH, Boneh A, Anderson V (2009) Cognitive, behavioural and adaptive profiles of children with glutaric aciduria type I detected through newborn screening. J Inherit Metab Dis 32 Suppl 1: S207-13.

[23] Simons A, Eyskens F, De Groof A et al (2006) Cognitive functioning and psychiatric disorders in children with a metabolic disease. Eur Child Adolesc Psychiatry 15: 207-13.

[24] Hoffmann GF, Athanassopoulos S, Burlina AB et al (1996) Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics 27: 115-23.

[25] Thies B, Meyer-Schwesinger C, Lamp J et al (2013) Acute renal proximal tubule alterations during induced metabolic crises in a mouse model of glutaric aciduria type 1. BiochimBiophysActa 1832: 1463-72.

[26] Pöge AP, Autschbach F, Korall H, Trefz FK, Mayatepek E (1997) Early clinical manifestation of glutaric aciduria type I and nephrotic syndrome during the first months of life. ActaPaediatr 86: 1144-7.

[27]Korman SH, Jakobs C, Darmin PS et al (2007) Glutaric aciduria type 1: clinical, biochemical and molecular findings in patients from Israel. Eur J PaediatrNeurol 11: 81-9.

[28] Herskovitz M, Goldsher D, Sela BA, Mandel H (2013) Subependymal mass lesions and peripheral polyneuropathy in adult-onset glutaric aciduria type I. Neurology 81: 849-50.

[29] Elpeleg ON, Colombo JP, Amir N, Bachmann C, Hurvitz H (1990) Late-onset form of partial N-acetylgutamatesynthetase deficiency. Eur J Pediatr 149:634-6.

[30] Guffon N, Vianey-Saban C, Bourgeois J et al (1995) A new neonatal case of N-acetylglutamate synthase deficiency treated by carbamylglutamate. J Inherit Metab Dis 18: 61-5.

[31] Plecko B, Erwa W, Wermuth B (1998) Partial N-acetylglutamate synthetase deficiency in a 13-year-old girl: diagnosis and response to treatment with N-carbamylglutamate. Eur J Pediatr 157: 996-8.

[32] Hinnie J, Colombo JP, Wermuth B, Dryburgh FJ (1997) N-Acetylglutamate synthetase deficiency responding to carbamylglutamate. J Inherit Metab Dis 20: 839-40

[33] Gelehrter TD, Snodgrass PJ (1974) Lethal neonatal deficiency of Carbamyl phosphate synthetase. N Engl J Med 290: 430-3.

[34] Summar ML, Dobbelaere D, Brusilow S, Lee B (2008) Diagnosis, symptoms, frequency and mortality of 260 patients with urea cycle disorders from a 21-year, multicenter study of acute hyperammonaemic episodes. ActaPaediatr 97: 1420-5.

[35] Eather G, Coman D, Lander C, McGill J (2006) Carbamyl phosphate synthase deficiency: diagnosed during pregnancy in a 41-year-old. J clinNeurosci 13: 702-6.

[36] Sperl W, Felber S, Skladal D, Wermuth B (1997) Metabolic stroke in carbamyl phosphate synthetase deficiency. Neuropediatrcs 28: 229-34.

[37]Takanashi J, Barkovich AJ, Cheng SF et al (2003) Brain MR imaging in neonatal hyperammonemic encephalopathy resulting from proximal urea cycle disorders. AJNR Am J Neuroradiol 24: 1184-7.

[38] Gropman AL, Summar M, Leonard JV (2007) Neurological implications of urea cycle disorders. J Inherit Metab Dis 30: 865-79.

[39] Call G, Seay AR, Sherry R, Qureshi IA (1984) Clinical features of Carbamyl phosphate synthetase-I deficiency in an adult. Ann Neurol 16: 90-3.

[40] Häberle J, Boddaert N, Burlina A et al (2012) Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis 7:32. doi: 10.1186/1750-1172-7-32.

[41] Bachmann C (1992) Ornithine carbamoyltransferase deficiency: findings, models and problems. J Inherit Metab Dis 15: 578-91.

[42] Nakamura K, Kido J, Mitsubuchi H, Endo F (2014) Diagnosis and treatment of urea cycle disorder in Japan. PediatrInt 56: 506-9.

[43]Batshaw ML, Tuchman M, Summar M et al (2014) A longitudinal study of urea cycle disorders. Mol Genet Metab 113: 127-30.

[44] Finkelstein JE, Hauser ER, Leonardo CO, Brusilow SW (1990). Late-onset ornithine transcarbamylase deficiency in male patients. J Pediatr 117: 897-902.

[45] Gallagher RC, Lam C, Wong D, Cederbaum S, Sokol RJ (2014) Significant hepatic involvement in patients with ornithine transcarbamylase deficiency. J Pediatr 164: 720-725.

[46] Mustafa A, Clarke JT (2006) Ornithine transcarbamoylase deficiency presenting with acute liver failure. J Inherit Metab Dis 29: 586.

[47] Teufel U, Weitz J, Flechtenmacher C et al (2011) High urgency liver transplantation in ornithine transcarbamylase deficiency presenting with acute liver failure. Pediatr Transplant 15: E110-5.

[48] Rüegger CM, Lindner M, Ballhausen D et al (2014) Cross-sectional observational study of 208 patients with non-classical urea cycle disorders. J Inherit Metab Dis 37: 21-30.

[49]Pridmore CL, Clarke JT, Blaser S (1995) Ornithine transcarbamylase deficiency in females: an often overlooked cause of treatable encephalopathy. J Child Neurol 10: 369-74.

[50] Rowe PC, Newman SL, Brusilow SW (1986) Natural history of symptomatic partial ornithine transcarbamylase deficiency. N Engl J Med 314:541-7.

[51] Gyato K, Wray J, Huang ZJ, Yudkoff M, Batshaw ML (2004) Metabolic and neuropsychological phenotype in women heterozygous for ornithine transcarbamylase deficiency. Ann Neurol 55: 80-6.

[52] Kido J, Nakamura K, Mitsubuchi H et al (2012) Long-term outcome and intervention of urea cycle disorders in Japan. J Inherit Metab Dis 35: 777-85.

[53]Celik O, Buyuktas D, Aydin A, Acbay O (2011) Ornithine transcarbamylase deficiency diagnosed in pregnancy. GynecolEndocrinol27: 1052-4.

[54] Danks DM, Tippett P, Zentner G (1974) Severe neonatal citrullinaemia. Arch Dis Child 49: 579-81.

[55] Ficicioglu C, Mandell R, Shih VE (2009) Argininosuccinatelyase deficiency: longterm outcome of 13 patients detected by newborn screening. Mel Genet Metab 98: 273-7.

[56] Mercimek-Mahmutoglu S, Moeslinger D, Häberle J et al (2010) Long-term outcome of patients with argininosuccinate lyase deficiency diagnosed by nowborn screening in Austria. Mol Genet Metab 100: 24-8.

[57] Margalith D, Crichton JU, Wong L et al (1983) Argininosuccinicaciduria. A developmental and biochemical case study. J NeuroloSci 60: 217-33

[58] Tuchman M, Lee B, Lichter-Konecki U et al (2008) Cross-sectional multicenter study of patients with urea cycle disorders in the United States. Mol Genet Metab 94: 397-402.

[59] Von Wendt L, Similä S, Ruokonen A, Puukka M (1982) Argininosuccinic aciduria in a Finnish woman presenting with psychosis and mental retardation. Ann Clin Res 14: 145-7.

[60] Brunetti-Pierri N, Erez A, Shchelochkov O, Craigen W, Lee B (2009) Systemic hypertension in two patients with ASL deficiency: a result of nitric oxide deficiency? Mol Genet Metab 98:195-7.

[61] Zimmermann A, Bachmann C, Baumgartner R (1986) Severe liver fibrosis in argininosuccinicaciduria. Arch Pathol Lab Med 110: 136-40.

[62] Mori T, Nagai K, Mori M et al (2002) Progressive liver fibrosis in late-onset argininosuccinate lyase deficiency. PediatrDevPathol 5: 597-601.

[63] Kvedar JC, Baden HP, Baden LA, Shih VE, Kolodny EH (1991) Dietary management reverses groofing and abnormal plarization of hair shafts in argininosuccinase deficiency. Am J Med Genet 40: 211-3.

[64] Fichtel JC, Richards JA, Davis LS (2007) Trichorrhexisnodosa secondary to argininosuccinicaciduria. PediatrDermatol 24: 25-7.

[65] Jain-Ghai S, Nagamani SC, Blaser S, Siriwardena K, Feigenbaum A (2011) Arginase I deficiency: severe infantile presentation with hyperammonemia: more common than reported? Mol Genet Metab 104:107-11

[66] Crombez EA, Cederbaum SD (2005) Hyperargininemia due to liver Arginase deficiency. Mol Genet Metab 84: 243-51.

[67]Scaglia F, Lee B (2006) Clinical, biochemical, and molecular spectrum of hyperargininemia due to Arginase I deficiency. Am J Med Genet C Semin Med Genet 142: 113-20.

[68]Debray FG, Lambert M, Lemieux B et al (2008) Phenotypic variability among patients with hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome homozygous for the delF188 mutation in SLC25A15. J Med Genet 45: 759-64.

[69] Salvi S, Santorelli FM, Bertini E et al (2001) Clinical and molecular findings in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome. Neurology 57: 911-4.

[70] Schwab MA, Sauer SW, Okun JG et al (2006) Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. Biochem J 398: 107-12.

[71] Marquard J, El Scheich T, Klee D et al (2011) Chronic pancreatitis in branched-chain organic acidurias – a case of methylmalonicaciduria and an overview of the literature. Eur J Pediatr 170: 241-5.

[72] Burlina AB, Dionisi-Vinci C, Piovan S et al (1995) Acute pancreatitis in propionic acidaemia. J Inherit Metab Dis 18: 169-72.

[73] Kahler SG, Sherwood WG, Woolf D et al (1994) Pancreatitis in patients with organic acidemias. J Pediatr 124: 239-43.

[74] Kölker S, Christensen E, Leonard JV et al (2011) Diagnosis and management of glutaric aciduria type I – revised recommendations. J Inherit Metab Dis 34: 677-94.

[75] Pena L, Franks J, Chapman KA et al (2012) Natural history of propionic acidemia. Mol Genet Metab 105: 5-9.

[76] Kelleher JF Jr, Yudkoff M, Hutchinson R, August CS, Cohn RM (1980) The pancytopenia of isovalericacidemia. Peidatrics 65: 1023-7.

[77] Guerra-Moreno J, Barrios N, Santiago-Borrero PJ (2003) Severe neutropenia in an infant with methylmalonicacidemia. BolAsoc Med P R 95: 17-20.

[78] Gokce M, Unal O, Hismi B et al (2012) Secondary hemophagocytosis in 3 patients with organic acidemia involving propionate metabolism. PediatrHematolOncol 29: 92-8.

[79] Gilbert-Barness E, Barness LA (1999) Isovalericacidemia with promyelocyticmyeloproliferative syndrome. PediatrDevPathol 2: 286-91.

[80] Cosson MA, Touati G, Lacaille F et al (2008) Liver hepatoblastoma and multiple OXPHOS deficiency in the follow-up of a patient with methylmalonicaciduria. Mol Genet Metab 98: 107-9.

[81] Niiyama S, Kölker S, Degen I et al (2001). Acrodermatitisacidemica secondary to malnutrition in glutaric aciduria type I. Eur J Dermatol 11: 244-46.

[82] Batshaw ML, MacArthur RB, Tuchman M (2001) Alternative pathway therapy for urea cycle disorders: twenty years later. J Pediatr 138: S46-54.

[83] Wilson JM, Shchelochkov OA, Gallagher RC, Batshaw ML (2012). Hepatocellular carcinoma in a research subject with ornithine transcarbamylase deficiency.Mol Genet Metab 105: 263-265.

[84] Carvalho DR, Brum JM, Speck-Martins CE et al (2012) Clinical features and neurologic progression of hyperargininemia. PediatrNeurol 46: 369-74.

[85] Jain-Ghai S, Nagamani SC, Blaser S, Siriwardena K, Feigenbaum A (2011) Arginase I deficiency: severe infantile presentation with hyperammonemia: More common than reported? Mol Genet Metab 104: 107-11.

[86] Fischer AQ, Challa VR, Burton BK, McLean WT (1981) Cerebellar hemorrhage complicating isovalericacidemia: a case report. Neurology 31: 746-48.

[87] Wilson CJ, Collins JE, Leonard JV (1999) Recurrentrhabdomyolysis in a child with glutaricaciduria type I.J Inherit Metab Dis 22: 663-4.

[88] Chow SL, Rohan C, Morris AAM (2003) Rhabdomyolysis in glutaricaciduria type I. J Inherit Metab Dis 26: 711-2.

[89] Jamuar SS, Newton SA, Prabhu SP et al (2012) Rhabdomyolysis, acute renal failure, and cardiac arrest secondary to status dystonicus in a child with glutaricaciduria type I Mol Genet Metab. 106:488-90.

[90] Karimzadeh P, Jafari N, Ahmad Abadi F (2014) Propionic acidemia: diagnosis and neuroimaging findings of this neurometabolic disorder. Iran J Child Neurol 8: 58-61.

[91] Rafique M (2013) Propionic acidaemia: demographic characteristics and complications. J PediatrEndocrinolMetab 26: 497-501.

[92] Ozgul RK, Karaca M, Kilic M et al (2014) Phenotypic and genotypic spectrum of Turkish patients with isovalericacidemia. Eur J Med Genet. 57:596-601.

[93] Østergaard E, Wibrand F, Ørngreen MC, Vissing J, Horn N (2005) Impaired energy metabolism and abnormal muscle histology in mut- methylmalonicaciduria. Neurology65:931-3.